Author： Bruno V.
Publisher： Elsevier
ISSN： 0924-977X
Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 339-340
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Clozapine for the treatment of schizophrenia
By Fakra Eric Azorin Jean-Michel
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 13, 2012-09 ,pp. :
Access to resources
Recommend
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
By Bitter I. Dossenbach M.R.K. Brook S. Feldman P.D. Metcalfe S. Gagiano C.A. Furedi J. Bartko G. Janka Z. Banki C.M. Kovacs G. Breier A. for the Olanzapine HGCK Study Group
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. :
By Kohn Y. Ebstein R.P. Heresco-Levy U. Shapira B. Nemanov L. Gritsenko I. Avnon M. Lerer B.
European Neuropsychopharmacology, Vol. 7, Iss. 1, 1997-02 ,pp. :